PetMed Deferred Long Term Liab vs Net Invested Capital Analysis

PETS Stock

USD 4.05 0.07 1.76%

PetMed Express financial indicator trend analysis is much more than just breaking down PetMed Express prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PetMed Express is a good investment. Please check the relationship between PetMed Express Deferred Long Term Liab and its Net Invested Capital accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Deferred Long Term Liab vs Net Invested Capital

Deferred Long Term Liab vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PetMed Express Deferred Long Term Liab account and Net Invested Capital. At this time, the significance of the direction appears to have strong relationship.

The correlation between PetMed Express' Deferred Long Term Liab and Net Invested Capital is 0.76. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of PetMed Express, assuming nothing else is changed. The correlation between historical values of PetMed Express' Deferred Long Term Liab and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of PetMed Express are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Deferred Long Term Liab i.e., PetMed Express' Deferred Long Term Liab and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.76

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from PetMed Express' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PetMed Express current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.At this time, PetMed Express' Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 100.56 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.15 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	78.1M	71.0M	81.7M	71.6M
Total Revenue	273.4M	256.9M	295.4M	210.1M

Gross Profit Total Revenue

PetMed Express fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Preferred Stock Total Equity
Total Assets		-0.6	0.76	0.92	0.86	0.81	-0.94	0.84	0.92	0.98	0.84	-0.35	0.99	0.63	0.72	0.69	0.08	0.29	0.77	0.63	0.91	0.81	0.86	-0.61	0.72	-0.48
Short Long Term Debt Total	-0.6		-0.31	-0.36	-0.68	-0.35	0.49	-0.72	-0.36	-0.46	-0.36	0.12	-0.53	-0.64	-0.96	-0.97	0.03	-0.73	-0.35	-0.26	-0.32	-0.35	-0.64	1.0	-0.96	0.1
Other Current Liab	0.76	-0.31		0.85	0.44	0.58	-0.59	0.37	0.74	0.74	0.7	0.22	0.75	0.17	0.51	0.49	0.36	0.01	0.84	0.66	0.88	0.58	0.48	-0.32	0.51	-0.76
Total Current Liabilities	0.92	-0.36	0.85		0.69	0.74	-0.85	0.64	0.98	0.92	0.79	-0.22	0.92	0.4	0.51	0.47	0.13	0.16	0.85	0.57	1.0	0.74	0.74	-0.36	0.51	-0.56
Total Stockholder Equity	0.86	-0.68	0.44	0.69		0.7	-0.91	0.99	0.74	0.84	0.68	-0.53	0.85	0.75	0.73	0.69	-0.07	0.4	0.54	0.44	0.66	0.7	0.98	-0.68	0.73	-0.02
Property Plant And Equipment Net	0.81	-0.35	0.58	0.74	0.7		-0.81	0.65	0.75	0.84	0.98	-0.24	0.78	0.5	0.49	0.43	0.14	-0.08	0.46	0.74	0.74	1.0	0.6	-0.35	0.49	-0.38
Net Debt	-0.94	0.49	-0.59	-0.85	-0.91	-0.81		-0.89	-0.89	-0.97	-0.8	0.54	-0.96	-0.69	-0.57	-0.53	0.0	-0.18	-0.66	-0.54	-0.83	-0.81	-0.9	0.49	-0.57	0.22
Retained Earnings	0.84	-0.72	0.37	0.64	0.99	0.65	-0.89		0.71	0.8	0.61	-0.58	0.82	0.8	0.74	0.71	-0.13	0.47	0.5	0.35	0.6	0.65	0.97	-0.72	0.74	0.03
Accounts Payable	0.92	-0.36	0.74	0.98	0.74	0.75	-0.89	0.71		0.93	0.77	-0.37	0.92	0.47	0.49	0.45	0.03	0.22	0.79	0.5	0.97	0.75	0.79	-0.37	0.49	-0.44
Cash	0.98	-0.46	0.74	0.92	0.84	0.84	-0.97	0.8	0.93		0.85	-0.41	0.99	0.61	0.59	0.55	0.09	0.12	0.74	0.64	0.91	0.84	0.83	-0.46	0.59	-0.46
Non Current Assets Total	0.84	-0.36	0.7	0.79	0.68	0.98	-0.8	0.61	0.77	0.85		-0.13	0.8	0.45	0.53	0.47	0.22	-0.09	0.54	0.8	0.8	0.98	0.59	-0.36	0.53	-0.5
Non Currrent Assets Other	-0.35	0.12	0.22	-0.22	-0.53	-0.24	0.54	-0.58	-0.37	-0.41	-0.13		-0.4	-0.6	-0.03	-0.03	0.41	-0.2	-0.14	0.12	-0.18	-0.24	-0.54	0.12	-0.03	-0.33
Cash And Short Term Investments	0.99	-0.53	0.75	0.92	0.85	0.78	-0.96	0.82	0.92	0.99	0.8	-0.4		0.64	0.65	0.62	0.07	0.21	0.76	0.6	0.91	0.78	0.86	-0.53	0.65	-0.47
Net Receivables	0.63	-0.64	0.17	0.4	0.75	0.5	-0.69	0.8	0.47	0.61	0.45	-0.6	0.64		0.59	0.59	-0.15	0.3	0.25	0.07	0.36	0.5	0.7	-0.64	0.59	0.02
Common Stock Total Equity	0.72	-0.96	0.51	0.51	0.73	0.49	-0.57	0.74	0.49	0.59	0.53	-0.03	0.65	0.59		0.99	0.06	0.63	0.47	0.46	0.48	0.49	0.69	-0.96	1.0	-0.3
Common Stock Shares Outstanding	0.69	-0.97	0.49	0.47	0.69	0.43	-0.53	0.71	0.45	0.55	0.47	-0.03	0.62	0.59	0.99		0.06	0.66	0.46	0.41	0.45	0.43	0.65	-0.97	0.99	-0.31
Non Current Liabilities Total	0.08	0.03	0.36	0.13	-0.07	0.14	0.0	-0.13	0.03	0.09	0.22	0.41	0.07	-0.15	0.06	0.06		-0.28	0.19	0.32	0.15	0.14	-0.1	0.02	0.06	-0.34
Inventory	0.29	-0.73	0.01	0.16	0.4	-0.08	-0.18	0.47	0.22	0.12	-0.09	-0.2	0.21	0.3	0.63	0.66	-0.28		0.27	-0.14	0.11	-0.08	0.45	-0.73	0.63	0.1
Other Current Assets	0.77	-0.35	0.84	0.85	0.54	0.46	-0.66	0.5	0.79	0.74	0.54	-0.14	0.76	0.25	0.47	0.46	0.19	0.27		0.42	0.85	0.46	0.62	-0.36	0.47	-0.56
Other Stockholder Equity	0.63	-0.26	0.66	0.57	0.44	0.74	-0.54	0.35	0.5	0.64	0.8	0.12	0.6	0.07	0.46	0.41	0.32	-0.14	0.42		0.6	0.74	0.36	-0.27	0.46	-0.57
Total Liab	0.91	-0.32	0.88	1.0	0.66	0.74	-0.83	0.6	0.97	0.91	0.8	-0.18	0.91	0.36	0.48	0.45	0.15	0.11	0.85	0.6		0.74	0.71	-0.32	0.48	-0.59
Property Plant And Equipment Gross	0.81	-0.35	0.58	0.74	0.7	1.0	-0.81	0.65	0.75	0.84	0.98	-0.24	0.78	0.5	0.49	0.43	0.14	-0.08	0.46	0.74	0.74		0.6	-0.35	0.49	-0.38
Total Current Assets	0.86	-0.64	0.48	0.74	0.98	0.6	-0.9	0.97	0.79	0.83	0.59	-0.54	0.86	0.7	0.69	0.65	-0.1	0.45	0.62	0.36	0.71	0.6		-0.64	0.69	-0.02
Short Term Debt	-0.61	1.0	-0.32	-0.36	-0.68	-0.35	0.49	-0.72	-0.37	-0.46	-0.36	0.12	-0.53	-0.64	-0.96	-0.97	0.02	-0.73	-0.36	-0.27	-0.32	-0.35	-0.64		-0.96	0.11
Common Stock	0.72	-0.96	0.51	0.51	0.73	0.49	-0.57	0.74	0.49	0.59	0.53	-0.03	0.65	0.59	1.0	0.99	0.06	0.63	0.47	0.46	0.48	0.49	0.69	-0.96		-0.3
Preferred Stock Total Equity	-0.48	0.1	-0.76	-0.56	-0.02	-0.38	0.22	0.03	-0.44	-0.46	-0.5	-0.33	-0.47	0.02	-0.3	-0.31	-0.34	0.1	-0.56	-0.57	-0.59	-0.38	-0.02	0.11	-0.3

Click cells to compare fundamentals

PetMed Express Account Relationship Matchups

PetMed Express fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	155.3M	187.5M	176.3M	164.1M	188.7M	198.2M
Other Current Liab	4.7M	5.4M	5.7M	11.3M	13.0M	13.6M
Total Current Liabilities	24.3M	44.9M	33.2M	36.5M	42.0M	44.1M
Total Stockholder Equity	130.0M	141.3M	142.2M	123.8M	142.4M	79.3M
Property Plant And Equipment Net	25.4M	25.5M	24.5M	26.2M	30.1M	31.6M
Net Debt	(103.8M)	(118.7M)	(111.1M)	(104.1M)	(93.7M)	(89.0M)
Retained Earnings	126.2M	134.1M	130.5M	105.5M	121.3M	71.7M
Accounts Payable	19.7M	39.5M	27.5M	25.2M	29.0M	30.4M
Cash	103.8M	118.7M	111.1M	104.1M	119.7M	125.7M
Non Current Assets Total	26.3M	26.3M	25.3M	32.7M	37.6M	39.4M
Non Currrent Assets Other	(26.3M)	(26.3M)	(25.3M)	5.9M	5.3M	5.5M
Cash And Short Term Investments	103.8M	118.7M	111.1M	104.1M	119.7M	125.7M
Net Receivables	3.8M	2.6M	1.9M	1.7M	2.0M	1.9M
Common Stock Shares Outstanding	20.1M	20.1M	20.4M	20.3M	23.4M	22.4M
Liabilities And Stockholders Equity	155.3M	187.5M	176.3M	164.1M	188.7M	198.2M
Non Current Liabilities Total	970K	1.3M	936K	3.8M	3.4M	3.6M
Inventory	17.9M	34.4M	32.5M	19.0M	21.9M	21.7M
Other Current Assets	3.5M	4.5M	5.5M	4.7M	5.4M	5.7M
Other Stockholder Equity	3.8M	7.1M	11.7M	18.3M	21.0M	22.1M
Total Liab	25.3M	46.2M	34.1M	40.3M	46.4M	48.7M
Property Plant And Equipment Gross	25.4M	25.5M	24.5M	26.2M	30.1M	31.6M
Total Current Assets	129.0M	161.2M	151.0M	131.5M	151.2M	78.0M
Property Plant Equipment	25.4M	25.5M	24.5M	26.2M	30.1M	31.6M
Net Tangible Assets	130.0M	141.3M	141.3M	123.8M	142.4M	114.5M
Retained Earnings Total Equity	126.2M	134.1M	130.5M	105.5M	121.3M	107.8M
Capital Surpluse	3.8M	7.1M	11.7M	18.3M	21.0M	22.1M
Other Liab	1.1M	970K	1.3M	936K	842.4K	852.3K
Net Invested Capital	130.0M	141.3M	142.2M	123.8M	142.4M	144.4M
Net Working Capital	104.7M	116.3M	117.8M	95.0M	109.2M	115.2M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PetMed Express in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PetMed Express' short interest history, or implied volatility extrapolated from PetMed Express options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PetMed Express using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:

How To Invest In PetMed

Details

Is PetMed Stock a good investment?

Details

What is PetMed Express' Net Worth?

Details

Largest Internet & Direct Marketing Retail Companies

View

Largest Consumer Discretionary Distribution & Retail Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for PetMed Stock analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital

Is PetMed Express' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetMed Express. If investors know PetMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.59)

Dividend Share

0.9

Earnings Share

(0.37)

Revenue Per Share

13.599

Quarterly Revenue Growth

0.11

The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PetMed Express' value and its price as these two are different measures arrived at by different means. Investors typically determine if PetMed Express is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetMed Express' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PetMed Deferred Long Term Liab vs Net Invested Capital Analysis

Deferred Long Term Liab vs Net Invested Capital

Deferred Long Term Liab vs Net Invested Capital Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Net Invested Capital

PetMed Express fundamental ratios Correlations

PetMed Express Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PetMed Express fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for PetMed Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity

Short Term Debt	- 0.97	Common Stock Shares Outstanding
Cash	- 0.97	Net Debt
Common Stock Shares Outstanding	- 0.97	Short Long Term Debt Total
Common Stock	- 0.96	Short Term Debt
Short Term Debt	- 0.96	Common Stock Total Equity
Cash And Short Term Investments	- 0.96	Net Debt